Biohaven Pharmaceutical Holding Co Ltd. (15)

Browse by Contract Category

Contracts

Underwriting Agreement, dated as of March 15, 2021, by and between the Company and Goldman Sachs & Co. LLC (Filed With SEC on March 17, 2021)
Agreement and Plan of Merger, dated as of January 1, 2021, by and between Biohaven Pharmaceutical Holding Company Ltd., Biohaven Therapeutics Ltd., Kleo Acquisition, Inc., Kleo... (Filed With SEC on January 8, 2021)
Amendment No. 1 (Filed With SEC on November 9, 2020)
Employment Agreement dated March 30, 2019 by and between Biohaven Pharmaceuticals, Inc. and William Jones, Jr (Filed With SEC on February 26, 2020)
Zydis Commercial Supply Agreement, dated as of June 29, 2018, by and between Biohaven Pharmaceuticals, Inc. and Catalent U.K. Swindon Zydis Limited (Filed With SEC on February 26, 2020)
Equity Distribution Agreement, dated as of December 23, 2020, by and between Biohaven Pharmaceutical Holding Company Ltd. and Goldman Sachs & Co. LLC, Piper Sandler & Co., SVB... (Filed With SEC on December 23, 2020)
Funding Agreement by and (Filed With SEC on November 9, 2020)
Series B Preferred Share Purchase Agreement by and (Filed With SEC on November 9, 2020)
Description of Biohaven's Securities Registered under Section 12 of the Exchange Act (Filed With SEC on February 26, 2020)
Employment Agreement dated February 1, 2014 by and between Biohaven Pharmaceuticals, Inc. and Kimberly A. Gentile (Filed With SEC on February 26, 2020)
Offer Letter dated April 5, 2017 by and between Biohaven Pharmaceuticals, Inc. and Elyse Stock (Filed With SEC on February 26, 2020)
Underwriting Agreement, dated as of January 28, 2020, by and between the Company and Goldman Sachs & Co. LLC (Filed With SEC on January 30, 2020)
Underwriting Agreement, dated as of June 18, 2019 by and among the Company and Goldman Sachs & Co. LLC and Piper Jaffray & Co., as Representatives of the several Underwriters... (Filed With SEC on June 21, 2019)
Series A Preferred Share Purchase Agreement, dated as of March 18, 2019 (Filed With SEC on May 8, 2019)
PRV Transfer Agreement (Filed With SEC on March 18, 2019)